Elmiron Lawsuits Filed for Patients with Vision Loss Due to Elmiron Use
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
We are handling Elmiron lawsuits for patients who have suffered vision loss due to their use of Elmiron. These Elmiron lawsuits are filed against the drug companies responsible for Elmiron. This is because — despite a growing number of Elmiron-related vision loss case reports in the medical literature over the past few years — it was not until June 2020 that any warning about eye problems was included in the Elmiron drug label here in the US.
This Elmiron label change in June 2020 finally added some warnings for serious eye problems such as retinal pigmentary changes and pigmentary maculopathy. From our perspective, these warnings about Elmiron eye side effects were long overdue.
We are currently investigating possible Elmiron lawsuits for patients diagnosed with eye problems such as:
- Vision Loss / Blindness
- Maculopathy (retinal or pigmentation)
- Retinal Pigmentary Endothelium Injury (RPE)
- Pigmentation Maculitis
- Macular Degeneration (pigmentation or dry)
It is important to know that our Elmiron lawsuits for patients who have suffered vision loss are filed only against the pharmaceutical companies responsible for Elmiron — not the doctors who prescribed the Elmiron as a treatment for their bladder diseases.
Significantly, it is not necessary for the patient to have been using Elmiron regularly right up until the time when their Elmiron-related vision loss was diagnosed in order to file an Elmiron lawsuit. That is, unlike most other drug injury cases, the patient could have stopped using Elmiron months before a medical doctor was able to diagnose their eye problem.
Please feel free to contact us if we can be of assistance to you in regards to a possible Elmiron lawsuit.
We encourage you to submit an Elmiron Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions – not an intake person, a paralegal, nor some other lawyer – about your case based on his many years of experience.
Most Recent Article About Elmiron
In December 2020, all Elmiron legal cases alleging eye damage and retinal injury filed in the federal courts were consolidated by means of an Elmiron MDL Order. These Elmiron legal cases are noteworthy as regards the monetary damages aspect of a lawsuit because these Elmiron-related eye problems can lead to vision loss or blindness.
From the Transfer Order issued for In Re: Elmiron [Pentosan Polysulfate Sodium] Products Liability Litigation, MDL Docket No. 2973, we get the following legal information:
To read more of this article, click below:
After considering the argument of counsel, we find that centralization of these actions in the District of New Jersey will serve the convenience of the parties and witnesses and promote the just and efficient conduct of the litigation. The actions involve common factual issues concerning the propensity of Elmiron to cause retinal injuries, notably atypical or pigmentary maculopathy. Several defendants have marketed Elmiron since its approval in 1996. This litigation likely will implicate complex scientific and regulatory issues. Centralization will eliminate duplicative discovery; avoid inconsistent pretrial rulings; and conserve the resources of the parties, their counsel and the judiciary. [Footnote omitted.]
Unlike most pharmaceutical drug injury lawsuits, for these Elmiron legal cases a person does not need to have been using Elmiron at the time when their eye damage or retinal injury was diagnosed by a doctor. This is because there can be a delay, or latency period, from a patient’s Elimiron “exposure” until there is Elmirion “toxicity” causing eye damage and retinal injury.
If we can be of assistance to you or someone else regarding a possible Elmiron lawsuit, you can send can submit an online Elmiron Case Evaluation Form or you can call us on our toll-free number: 800-426-9535.[Read article in full at original source]
Our earlier articles about Elmiron:
- Elmiron Updates: Legal, Medical, and Regulatory – December 2020
- Are Elmiron Side Effects Risks for Eye and Vision Are Greater Than Its Bladder Treatment Benefits?
- Elmiron Lawsuits Being Filed Against Drug Companies for Elmiron-Related Eye Problems
- FDA Announces Elmiron Drug Safety-Related Labeling Changes
- Elmiron Potentially Linked to Severe Eye Disorders